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Abstract
Background: A low yield of lymph nodes (LN) in abdominoperineal resection (APR) specimen has
been associated with preoperative radiation therapy (XRT) in population-based studies, which may
preclude adequate staging of anorectal carcinomas. We hypothesized that the number of LN
retrieved in APR specimen was correlated with the dose and the timing of pelvic irradiation.
Patients and methods: We performed a retrospective study of 102 patients who underwent
APR in a single institution between 1980 and 2004. Pathological reports were reviewed and the
number of lymph nodes retrieved in APR specimens was correlated with: 1) Preoperative radiation;
2) Dose of pelvic irradiation; and 3) Time interval between the end of XRT and surgery.
Results: There were 61 men and 41 women, with a median age of 66 (range 25–89) years. There
were 12 patients operated for squamous cell carcinoma of the anal canal (SCCA) and 90 for rectal
cancer. 83% and 46% of patients with anal and rectal cancer respectively underwent radical/
neoadjuvant radiotherapy. The mean ± SD number of LN in APR specimen was 9.2 ± 5.9. The mean
number of LN in APR specimen was significantly lower in patients who underwent preoperative
XRT (8 ± 5.5 vs. 10.5 ± 6.1, Mann-Whitney U test, p = 0.02). The mean number of LN was not
significantly different after XRT in patients with SCCA than in patients with rectal cancer (6.2 ± 5.3
vs. 7.8 ± 5.3, p = 0.33). Finally, there was an inverse correlation between the yield of LN and the
time elapsed between XRT and surgery (linear regression coefficient r = -0.32, p = 0.03).
Conclusion: Our data indicate that: 1) radiation therapy affects the yield of LN retrieval in APR
specimen; 2) this impact is time-dependent. These findings have important implications with regard
to anatomic-pathological staging of anal and rectal cancers and subsequent decision-making
regarding adjuvant chemotherapy.
Introduction
Adequate surgical lymphadenectomy and pathological
evaluation of lymph nodes is a prerequisite for tumor
staging and subsequent decision regarding adjuvant
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rectal cancer [1]. In the 1997 TNM classification, of both
the American Joint Committee on Cancer (AJCC) and the
International Union Against Cancer (UICC), it is recom-
mended that histological examination of a colorectal car-
cinoma (CRC) specimen should include a minimum of
12 lymph nodes [2]. This statement, however, was not
intended to be a requirement for pN0, but rather a guide-
line, and it appears that these criteria are met only in 31%
of the patients with rectal cancer [3]. This has important
implications in clinical practice, since examination of
nine or fewer lymph nodes is related to poor prognosis in
patients with node-negative CRC [4-6].
Ionizing radiation has significant effects on the morphol-
ogy of lymph nodes, including lymphocyte depletion and
stroma fibrosis [7]. Indeed, data from population-based
cancer registry indicate that preoperative XRT may have a
negative impact on the number of lymph nodes retrieved
from surgical specimen [8]. Other factors, which may
affect lymph nodes yield in rectal cancer specimen,
include tumor size, as well as examination by a dedicated
histopathologist [9-11].
The aim of this study was to better define the impact of
XRT in a population of patients who underwent abdomi-
noperineal resection (APR) with or without previous XRT.
We hypothesized; 1) that the yield of LN retrieval in APR
specimen was lower in patients who had preoperative
XRT; 2) that the effect of radiation on LN retrieval was
dose-dependant; and 3) that the impact of preoperative
XRT was time-dependent (i.e. the longer the delay
between XRT and surgery, the more severe the lymph
node depletion).
Patients and methods
This is a retrospective study of consecutive series of
patients, who had underwent abdominoperineal resec-
tion for a histologically proven adenocarcinoma of the
rectum or squamous cell carcinoma of the anal canal at
University Hospital Geneva between September 1980 and
February 2004. The total number of lymph nodes identi-
fied within the APR specimen was derived from the histol-
ogy report in each case. Using these reports together with
the patient notes the following information was recorded
for each patient: age, gender, site of tumor (anal canal or
lower rectum), TNM stage, preoperative radiotherapy sta-
tus (short-course, long-course or none), dose of radiation
delivered to the tumor, and finally the time elapsed
between the end of XRT and surgical resection.
Radiation techniques
Patients with anal cancer were irradiated according to a
previously described protocol [12]. Shortly, external beam
radiation therapy (EBRT) was delivered in two sequences,
with generally a median gap of 6 weeks or less between
the sequences. For the first sequence external beam radia-
tion therapy (EBRT) was used to a median dose of 39.6 Gy
using mega-voltage photon beams. Boost treatment con-
sisted of an additional dose of 20 Gy to the initial
involved areas either using EBRT or brachytherapy.
Patients with rectal cancer were treated preoperatively to a
total dose of 45–50 Gy or a biologically equivalent dose
using different RT fractionations as previously described
[13]. The initial target volume included the tumor and any
enlarged lymph nodes, perirectal and internal iliac lymph
nodes, as well as the presacral area. Generally one poste-
rior and two lateral Mega-voltage photon beams were
used.
Surgical technique
The standardized procedure for APR included full mobili-
zation of the rectum with sharp dissection in the plane
anterior to Waldeyer's fascia down to the level of the leva-
tor muscles, in accordance with the Total Mesorectum
Excision (TME) technique. Proximal section of the sig-
moid colon was performed after ligature of the superior
rectal artery or the inferior mesenteric artery. The perineal
dissection encompassed the perianal skin, anal sphincters
before dividing laterally the levators and the anal coccy-
geal ligament posteriorly.
Histological technique
Dissection of the specimen was performed according to a
standard operating procedure, which did not change sig-
nificantly over the course of the study. Lymph nodes were
identified by direct inspection and manual palpation after
close transverse slicing of the mesorectum and sigmoid
mesentery. Histological technique involved careful stand-
ard dissection and direct inspection. Neither fat clearance,
nor sentinel node mapping methods were used in this
series of patients.
Statistical analysis
Statistical analyses were undertaken by means of the soft-
ware package Statgraph 3.0 software for Windows (Stat-
graph Software Inc., San Diego, CA). Quantitative data
were expressed as mean ± SD, or median (range). Groups'
comparisons were made using Fisher's exact test for cate-
gorical variables, and Student t-test, Mann-Whitney U test
or analysis of variance (ANOVA) for continuous variables.
P-values less than or equal to a two-sided alpha-level of
0.05 were considered statistically significant.
Results
There were 61 men and 41 women, with a median age of
66 (range 25–89) years. 12 patients underwent APR for
SCCA and 90 for rectal cancer. Ten (83%) SCCA patients
and 42 (46%) rectal cancer patients underwent preopera-
tive radiotherapy. The clinico-pathological characteristicsPage 2 of 5
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tus are summarized in Table 1. Six patients had no evi-
dence of residual tumor within the surgical specimen
(Stage 0). There were 30 Stage I, 20 stage II, and 46 stage
III patients. Of these, 44% of patients had positive lymph
nodes (N1-2) in the specimen. The mean delay between
the end of XRT and surgery was 151 (range 57–231) days
in SCCA patients, and 49 (4–229) days in patients with
rectal cancer (Mann-Whitney U test, p = 0.001).
Yield of LN retrieval in APR specimen according to XRT 
status
When considering all patients together, the mean number
of LN in surgical specimen was 9.2 ± 5.9 (median 8, range
0–24). The mean number of LN in APR specimen was sig-
nificantly lower in patients who underwent preoperative
XRT (8 ± 5.5 vs. 10.5 ± 6.1, Mann-Whitney U test p = 0.02)
(Figure 1).
The effects of preoperative XRT according to the dose of 
irradiation
We compared the number of LN in APR specimen of 10
SCCA patients (who received a mean dose to the pelvis of
60 Gy) with 42 rectal cancer patients who were treated
with a mean dose of 45 Gy. The mean number of LN was
lower after XRT in patients with SCCA than in patients
with rectal cancer; however, this difference did not reach
statistical significance (6.2 ± 5.3 vs. 7.8 ± 5.3, p = 0.33)
(Figure 2).
The effects of preoperative XRT are time-dependent
Finally, we performed a regression analysis of the number
of LN according to the delay between the end of XRT and
the time of surgery. The median time elapsed was 50 days
(range 4–231), and this delay was significantly longer in
patients with SCCA than in patients with rectal cancer
(151 ± 79 vs. 49 ± 35 days, p < 0.001). There was an
inverse correlation between the yield of LN and the time
elapsed between XRT and surgery (linear regression coef-
ficient r = -0.32, p = 0.03) (Figure 3).
Discussion
In this series the number of LN retrieved in APR specimen
of rectal cancer patients with (8 LN) or without (10.5 LN)
preoperative XRT are quite similar to large population-
based series from the US [3], and Europe [14], suggesting
that the techniques of surgical lymphadenectomy and
pathological examination used in our institution are ade-
quate. Although this 25% reduction in LN yield may seem
of little clinical significance, it is noteworthy that 31% of
patients in the irradiated group had 4 or less nodes in their
surgical specimen, suggesting inadequate tumor staging in
one third of patients who underwent preoperative radia-
tion therapy. Thus, our first hypothesis proved to be cor-
rect; preoperative XRT significantly and negatively affects
the yield of LN in APR specimen.
By contrast, we were unable to demonstrate that our sec-
ond hypothesis was correct; although patients with SCCA
were irradiated with higher doses, in comparison with rec-
tal cancer patients, the difference in the number of LN
according to the tumor type failed to achieve statistical sig-
nificance. Actually, (and this demonstrates our third
hypothesis to be right) our data emphasizes the impact of
timing, more than the actual dose of radiation, on the
number of lymph nodes retrieved from APR specimen.
The impact of XRT on mesorectum lymph node retrieval
is more pronounced when APR is delayed by several
months after the end of pelvic irradiation [15]. The regres-
sion analysis in our study was greatly influenced by the 5
patients who underwent APR for recurrent anal cancer
more than 5 months after the end of radiation therapy.
Consequently, current protocols with longer intervals (6–
8 weeks) between XRT and surgery for rectal cancer may
result in increased tumor downstaging, but also in an
Table 1: Clinicopathological characteristics of patients according to preoperative radiation therapy
CRT NO CRT p
Age (median, range) 61.5 (25–82) 67.5 (28–89) 0.33
Male gender (%) 61.5 58 0.84
Indication for APR 0.001
Anal cancer 10 2
Rectal cancer 42 48
LN retrieved 8.0 ± 5.5 10.5 ± 6.1 0.02
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[16,17].
The implications of our results are that, due to the wide-
spread use of neoadjuvant XRT, the current TNM classifi-
cation of anorectal cancers needs to be improved [18].
Pre-treatment staging using either magnetic resonance
imaging or endorectal ultrasound (EUS) are accurate
enough for the T stage, but have proven insufficient to
determine lymph node involvement [19,20]. By compari-
son, and despite tumor down staging, pathological post-
operative staging remained a very strong prognostic factor
for both T and N stages [21,22]. Thus, the TNM staging
system for rectal cancer, which currently does not take
into account neoadjuvant XRT, remains pivotal for selec-
tion of patients who may benefit from additional chemo-
therapy, but the pathological N staging of irradiated
specimen should be interpreted with caution.
Summary
The longer is the delay between XRT and surgery, the
lower is the yield of LN in the mesorectum. Future efforts
for improving the yield of mesorectal lymph node after
pelvic irradiation should consider reinvestigating the role
of extended but selective lymphadenectomy, perhaps
using modern techniques of lymph node clearing [23].
Sentinel lymph node mapping is another promising
option, which needs to be assessed in prospective studies
[24,25].
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